The Experts below are selected from a list of 49497 Experts worldwide ranked by ideXlab platform

Sane Ishikawa - One of the best experts on this subject based on the ideXlab platform.

  • possible vascular role of increased plasma arginine vasopressin in Congestive Heart Failure
    2006
    Co-Authors: Tomohiro Nakamura, Hiroshi Funayama, Akio Yoshimura, Yoshio Tsuruya, Muneyasu Saito, Masanobu Kawakami, Sane Ishikawa
    Abstract:

    Abstract Background The present study was undertaken to determine the relation of cardiac dysfunction with hormonal release in patients with Congestive Heart Failure. Methods Seventy-two patients with Congestive Heart Failure were examined, who were divided into four subgroups classified by the criteria of the New York Heart Association (NYHA). Also, 10 age-matched subjects were served as a control. Plasma arginine vasopressin (AVP), norepinephrine, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were determined. Cardiac index and pulmonary capillary wedge pressure (PCWP) were measured in 51 of 72 patients. Results Plasma AVP levels were significantly increased according to the severity of NYHA classes; control: 1.7±0.2; NYHA I: 4.9±0.8, NYHA II: 5.5±0.9, NYHA III: 13.4±2.6 ( p p r =−0.36, p r =0.44, p Conclusion The present study indicates that increased AVP may deteriorate cardiac function through V 1a as well as V 2 action, and that plasma AVP level is also a proper marker for the presence and severity of Congestive Heart Failure.

Daniel Levy - One of the best experts on this subject based on the ideXlab platform.

  • left ventricular dilatation and the risk of Congestive Heart Failure in people without myocardial infarction
    1997
    Co-Authors: Ramachandran S Vasan, Martin G Larson, Emelia J Benjamin, Jane C Evans, Daniel Levy
    Abstract:

    Background Left ventricular dilatation is a well-recognized precursor of ventricular dysfunction and Congestive Heart Failure after myocardial infarction. The effect of left ventricular dilatation on the risk of Heart Failure in people initially free of myocardial infarction is not known. Methods We examined the relation of the left ventricular end-diastolic and end-systolic internal dimensions, as measured by M-mode echocardiography, to the risk of Congestive Heart Failure in 4744 subjects (2661 women and 2083 men) who had not sustained a myocardial infarction and who were free of Congestive Heart Failure. We used sex-stratified proportional-hazards regression to assess the association between base-line left ventricular internal dimensions and the subsequent risk of Congestive Heart Failure, after adjusting for age, blood pressure, hypertension treatment, body-mass index, diabetes, valve disease, and interim myocardial infarction. Results Over an 11-year follow-up period, Congestive Heart Failure develop...

Rifai Akhmad - One of the best experts on this subject based on the ideXlab platform.

  • HIPERVOLEMIA PADA PASIEN Congestive Heart Failure (CHF)
    2018
    Co-Authors: Astuti, Yeni Eka, Setyorini Yuyun, Rifai Akhmad
    Abstract:

    Background: Congestive Heart Failure (CHF) is a condition in which the Heart is unable to pump blood normally, causing disturbed venous return pressure to cause edema. The problem that arises is hypervolemia or intracellular fluid resuscitation to the interstitial that causes edema so that can be arranged nursing intervention one of them is giving diuretic and monitor fluid balance. Describes nursing care performed in Congestive Heart Failure (CHF) patients with hypervolemia. Method: This study uses data analysis method that is conducting the nursing process of two patients Congestive Heart Failure (CHF) who suffered from Hypervolemia disorder and then compared with case study journal as well as other sources. Result: After nursing action in both patients the Hipervolemia problem is equally partially resolved by fluid restriction nursing interventions, and the administration of diuretics. Conclusion: In providing nursing care to patients with Congestive Heart Failure (CHF) should pay attention to fluid restriction and appropriate diuretic administration to reduce edema. Keyword: Congestive Heart Failure (CHF), Hipervolemia, Nursing Care LINK OJS 3 ARTIKEL "HIPERVOLEMIA PADA PASIEN Congestive Heart Failure (CHF)

  • Hipervolemia Pada Pasien Congestive Heart Failure (CHF)
    2018
    Co-Authors: Astuti, Yeni Eka, Setyorini Yuyun, Rifai Akhmad
    Abstract:

    Background: Congestive Heart Failure (CHF) is a condition in which the Heart is unable to pump blood normally, causing disturbed venous return pressure to cause edema. The problem that arises is hypervolemia or intracellular fluid resuscitation to the interstitial that causes edema so that can be arranged nursing intervention one of them is giving diuretic and monitor fluid balance. Describes nursing care performed in Congestive Heart Failure (CHF) patients with hypervolemia. Method: This study uses data analysis method that is conducting the nursing process of two patients Congestive Heart Failure (CHF) who suffered from Hypervolemia disorder and then compared with case study journal as well as other sources. Result: After nursing action in both patients the Hipervolemia problem is equally partially resolved by fluid restriction nursing interventions, and the administration of diuretics. Conclusion: In providing nursing care to patients with Congestive Heart Failure (CHF) should pay attention to fluid restriction and appropriate diuretic administration to reduce edema

Tomohiro Nakamura - One of the best experts on this subject based on the ideXlab platform.

  • possible vascular role of increased plasma arginine vasopressin in Congestive Heart Failure
    2006
    Co-Authors: Tomohiro Nakamura, Hiroshi Funayama, Akio Yoshimura, Yoshio Tsuruya, Muneyasu Saito, Masanobu Kawakami, Sane Ishikawa
    Abstract:

    Abstract Background The present study was undertaken to determine the relation of cardiac dysfunction with hormonal release in patients with Congestive Heart Failure. Methods Seventy-two patients with Congestive Heart Failure were examined, who were divided into four subgroups classified by the criteria of the New York Heart Association (NYHA). Also, 10 age-matched subjects were served as a control. Plasma arginine vasopressin (AVP), norepinephrine, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were determined. Cardiac index and pulmonary capillary wedge pressure (PCWP) were measured in 51 of 72 patients. Results Plasma AVP levels were significantly increased according to the severity of NYHA classes; control: 1.7±0.2; NYHA I: 4.9±0.8, NYHA II: 5.5±0.9, NYHA III: 13.4±2.6 ( p p r =−0.36, p r =0.44, p Conclusion The present study indicates that increased AVP may deteriorate cardiac function through V 1a as well as V 2 action, and that plasma AVP level is also a proper marker for the presence and severity of Congestive Heart Failure.

N E Breslow - One of the best experts on this subject based on the ideXlab platform.

  • Congestive Heart Failure after treatment for wilms tumor a report from the national wilms tumor study group
    2001
    Co-Authors: Daniel M Green, Pat Norkool, Janice R. Takashima, Yevgeny A. Grigoriev, Bin Nan, G J Dangio, N E Breslow
    Abstract:

    PURPOSE: We determined the frequency of and risk factors for Congestive Heart Failure following treatment for Wilms’ tumor that included doxorubicin. PATIENTS AND METHODS: Flow sheets and medical records were reviewed to identify cases of Congestive Heart Failure in a cohort of patients treated on National Wilms’ Tumor Studies (NWTS)-1, -2, -3, and -4. The frequency of Congestive Heart Failure was estimated using the Kaplan-Meier method. A case-control study was conducted to determine the relationship among cumulative doxorubicin dose, site(s), total dose of abdominal and thoracic irradiation, sex, and the frequency of Congestive Heart Failure. RESULTS: The cumulative frequency of Congestive Heart Failure was 4.4% at 20 years after diagnosis among patients treated initially with doxorubicin and 17.4% at 20 years after diagnosis among those treated with doxorubicin for their first or subsequent relapse of Wilms’ tumor. The relative risk (RR) of Congestive Heart Failure was increased in females (RR = 4.5; P...